DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (76)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 76   Next >>

Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-21

Patient: male

Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: male

Reactions: Bladder Dilatation, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Cytogenetic Abnormality, Brain Malformation, Spina Bifida, Abortion Induced, Vertical Talus

Adverse event resulted in: death

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Isentress
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a consumer/non-health professional from France on 2012-08-16

Patient: male

Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Start date: 2012-01-24

Reyataz
    Start date: 2012-01-24

Truvada
    Start date: 2011-01-24



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: male

Reactions: Bladder Dilatation, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Hypoplastic Left Heart Syndrome, Foetal Exposure During Pregnancy, Stillbirth, Heart Disease Congenital

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Product Used FOR Unknown Indication



Possible Reyataz side effects in 57 year old female

Reported by a physician from United States on 2012-08-10

Patient: 57 year old female

Reactions: Chronic Obstructive Pulmonary Disease, Myocardial Infarction, Arrhythmia

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-06

Patient: male

Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Start date: 2012-01-24

Reyataz
    Start date: 2012-01-24

Truvada
    Start date: 2011-01-24



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: male

Reactions: Dysmorphism, Bladder Dilatation, Rectal Perforation, Amniotic Fluid Volume Decreased, Renal Aplasia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Dosage: unk
    Indication: HIV Infection
    Start date: 2012-01-01

Reyataz
    Dosage: unk
    Indication: HIV Infection
    Start date: 2012-01-01

Truvada
    Dosage: unk
    Indication: HIV Infection
    Start date: 2012-01-01



Possible Reyataz side effects in male

Reported by a physician from France on 2012-07-30

Patient: male

Reactions: Foetal Exposure During Pregnancy, Intestinal Malrotation, Renal Dysplasia, Persistent Cloaca, Trisomy 21, Cleft Palate, Bladder Dilatation, Protrusion Tongue, Amniotic Fluid Volume Decreased, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified
    Start date: 2012-01-24

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in 27 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 27 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: HIV Infection

Reyataz
    Indication: Acquired Immunodeficiency Syndrome



Possible Reyataz side effects in 81 year old female

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: 81 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-07-09

Patient: 57 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 41 year old female

Reported by a physician from Canada on 2012-06-29

Patient: 41 year old female

Reactions: Breast Cancer, Back Pain, Weight Increased, Breast Cancer Metastatic, Hydrocephalus, Metastases To Bone

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Lamivudine
    Indication: HIV Infection
    Start date: 2006-05-12

Norvir
    Indication: HIV Infection
    Start date: 2006-03-12

Reyataz
    Indication: HIV Infection
    Start date: 2006-05-12

Study Drug MK-0518 (Non-Abbott)
    Dosage: blinded treatment
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-05-12
    End date: 2009-05-13

Study Drug MK-0518 (Non-Abbott)
    Administration route: Oral
    Start date: 2009-03-14
    End date: 2010-07-07

Viread
    Indication: HIV Infection
    Start date: 2006-05-12

Other drugs received by patient: Robaxin; Oxycodone HCL; Ibuprofen (Advil); Acetaminophen; Palafer; Acetaminophen; Zomig; Dilaudid



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-24

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 56 year old male

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: 56 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 27 year old male

Reported by a consumer/non-health professional from United States on 2012-06-15

Patient: 27 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Acquired Immunodeficiency Syndrome

Reyataz
    Indication: HIV Infection



Possible Reyataz side effects in 23 year old male

Reported by a pharmacist from United States on 2012-06-11

Patient: 23 year old male

Reactions: Hepatitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: 57 year old male

Reactions: Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Abacavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-20

Reyataz
    Dosage: started art in 2000
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-20

Ritonavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-20

Zidovudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-20

Other drugs received by patient: Minoxidil; Lovastatin; Clonidine; Phoslo; Lantus; Hydralazine HCL



Possible Reyataz side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 50 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23

Patient: 31 year old male

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in female

Reported by a consumer/non-health professional from France on 2012-05-23

Patient: female

Reactions: Congenital Central Nervous System Anomaly

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Start date: 2005-10-01

Reyataz
    Start date: 2005-01-01

Truvada
    Start date: 2005-10-01



Possible Reyataz side effects in 57 year old male

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: 57 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12

Patient:

Reactions: Trisomy 21, Abortion, Foetal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Isentress
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Tenofovir Disoproxil Fumarate
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient:

Reactions: Trisomy 21, Foetal Exposure During Pregnancy, Abortion

Adverse event resulted in: death

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Isentress
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Tenofovir Disoproxil Fumarate
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in 57 year old male

Reported by a consumer/non-health professional from United States on 2012-04-03

Patient: 57 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 66 year old male

Reported by a physician from Japan on 2012-03-15

Patient: 66 year old male

Reactions: Blood Alkaline Phosphatase Increased, Gastrointestinal Haemorrhage, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epzicom
    Dosage: 1 df = 1 tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-04-03
    End date: 2010-04-20

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-04-03
    End date: 2010-04-20

Zithromax
    Indication: Prophylaxis
    Start date: 2010-04-03
    End date: 2010-04-17



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014